Ledger.Open graph →
SEC Form D · filed September 24, 2020

Cedilla Therapeutics, Inc

Offering
$60.0M
Sold
$30.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Dominik Naczynski · Cambridge, MADirectorRosana Kapeller · Cambridge, MADirectorEli Casdin · San Francisco, CADirectorNeil Exter · New York, NYDirectorAbbie Celniker · Boston, MADirectorAlexandra Glucksmann · Cambridge, MAExec · DirectorEli Casdin · San Francisco, CADirectorNeil Exter · Boston, MADirectorDominik Naczynski · Cambridge, MADirectorRosana Kapeller · Cambridge, MADirectorAbbie Celniker · Boston, MADirectorAlexandra Glucksmann · Cambridge, MAExec · DirectorEli Casdin · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗